As of 2026-05-24, the EV/EBITDA ratio of SMS Pharmaceuticals Ltd (SMSPHARMA.NS) is 21.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SMSPHARMA.NS's latest enterprise value is 37,970.92 mil INR. SMSPHARMA.NS's TTM EBITDA according to its financial statements is 1,780.69 mil INR. Dividing these 2 quantities gives us the above SMSPHARMA.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 13.3x | 11.1x |
| Forward P/E multiples | 8.4x - 12.3x | 10.4x |
| Fair Price | 153.21 - 254.53 | 199.47 |
| Upside | -59.8% - -33.3% | -47.7% |
| Date | EV/EBITDA |
| 2026-05-22 | 21.32 |
| 2026-05-21 | 23.57 |
| 2026-05-20 | 23.62 |
| 2026-05-19 | 22.75 |
| 2026-05-18 | 22.06 |
| 2026-05-15 | 22.30 |
| 2026-05-14 | 22.25 |
| 2026-05-13 | 22.43 |
| 2026-05-12 | 22.67 |
| 2026-05-11 | 23.27 |
| 2026-05-08 | 22.98 |
| 2026-05-07 | 23.60 |
| 2026-05-06 | 23.04 |
| 2026-05-05 | 22.55 |
| 2026-05-04 | 22.83 |
| 2026-04-30 | 22.61 |
| 2026-04-29 | 22.93 |
| 2026-04-28 | 21.88 |
| 2026-04-27 | 22.25 |
| 2026-04-24 | 22.09 |
| 2026-04-23 | 23.04 |
| 2026-04-22 | 23.43 |
| 2026-04-21 | 22.76 |
| 2026-04-20 | 23.27 |
| 2026-04-17 | 23.89 |
| 2026-04-16 | 23.46 |
| 2026-04-15 | 24.33 |
| 2026-04-13 | 23.19 |
| 2026-04-10 | 23.22 |
| 2026-04-09 | 22.99 |
| 2026-04-08 | 22.29 |
| 2026-04-07 | 21.72 |
| 2026-04-06 | 21.72 |
| 2026-04-02 | 21.72 |
| 2026-04-01 | 21.93 |
| 2026-03-30 | 20.86 |
| 2026-03-27 | 21.62 |
| 2026-03-25 | 22.51 |
| 2026-03-24 | 22.09 |
| 2026-03-23 | 20.88 |
| 2026-03-20 | 21.61 |
| 2026-03-19 | 20.47 |
| 2026-03-18 | 21.43 |
| 2026-03-17 | 20.93 |
| 2026-03-16 | 20.54 |
| 2026-03-13 | 20.65 |
| 2026-03-12 | 22.40 |
| 2026-03-11 | 23.09 |
| 2026-03-10 | 23.43 |
| 2026-03-09 | 21.51 |